Olympus America introduces new V-System for ERCP procedure

Olympus America Inc., a precision technology leader designing and delivering innovative solutions in medical and surgical products among other core business areas, today launched its new V-System. The new V-System combines Olympus' latest duodenoscope, the TJF-Q180V, with its unique V-System devices for the endoscopic retrograde cholangiopancreatography (ERCP) procedure. The TJF-Q180V is the first duodenoscope to feature Narrow Band Imaging (NBI) and a dual guidewire locking mechanism that securely supports a short guidewire exchange. The scope also features a larger and higher resolution image than its predecessor. The new V-System was developed by Olympus to help address the challenges of the ERCP procedure and allow physicians to achieve and maintain access to the biliary system with greater ease.

The new V-System also provides physicians with a choice of distally wire-guided or conventional over-the-wire devices. The guidewire locking mechanism on the new TJF-Q180Vsecurely locks a 0.025 inch or 0.035 inch guidewire to support a short guidewire exchange. Traditionally, short-wire systems have been limited in their ability to use devices other than those sold with the proprietary system. The new Olympus V-System has been designed as an "open system," which offers clinicians the flexibility to combine other proprietary devices to best match their clinical needs and achieve cost efficiency.

"I consider the TJF-Q180V to be the new gold standard in ERCP technology," said David R. Lichtenstein, MD, director of endoscopy at Boston Medical Center. "The development of the V-System by Olympus offers the freedom to choose between long and short-wire approaches and solo endoscopy versus assistant-aided guidewire manipulation. In my experience, the enhanced V-System allows for faster device exchanges, less fluoroscopy time, and single operator manipulation of the guidewire during cannulation, translating into a potential reduction in complications such as pancreatitis," added Lichtenstein.

"The V-System is a result of our company's focus on endoscopic innovation and meeting the needs of our customers," said Patrick MacCarthy, Vice President of EndoTherapy for Olympus America's Medical Systems Group. "The physicians, nurses and technicians that we serve have asked for an ERCP solution that will enable short-wire exchange, but also include the flexibility to switch between physician and assistant control of the devices. They also demanded that the system be "open," so that their device choices would not be limited to one company. We listened, and I'm delighted to say that we can now deliver a solution that will allow for the best patient care, while also driving cost efficiency."

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Evident Corporation - Life Sciences. (2019, June 20). Olympus America introduces new V-System for ERCP procedure. News-Medical. Retrieved on December 22, 2024 from https://www.news-medical.net/news/20100810/Olympus-America-introduces-new-V-System-for-ERCP-procedure.aspx.

  • MLA

    Evident Corporation - Life Sciences. "Olympus America introduces new V-System for ERCP procedure". News-Medical. 22 December 2024. <https://www.news-medical.net/news/20100810/Olympus-America-introduces-new-V-System-for-ERCP-procedure.aspx>.

  • Chicago

    Evident Corporation - Life Sciences. "Olympus America introduces new V-System for ERCP procedure". News-Medical. https://www.news-medical.net/news/20100810/Olympus-America-introduces-new-V-System-for-ERCP-procedure.aspx. (accessed December 22, 2024).

  • Harvard

    Evident Corporation - Life Sciences. 2019. Olympus America introduces new V-System for ERCP procedure. News-Medical, viewed 22 December 2024, https://www.news-medical.net/news/20100810/Olympus-America-introduces-new-V-System-for-ERCP-procedure.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
EVIDENT Announces 2021 Global Image of the Year Award Winners